176 related articles for article (PubMed ID: 17049344)
1. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism.
Lee AM; Joshi M; Yue J; Tyndale RF
Eur J Pharmacol; 2006 Dec; 552(1-3):151-8. PubMed ID: 17049344
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment.
Lee AM; Yue J; Tyndale RF
Drug Metab Dispos; 2006 Sep; 34(9):1508-15. PubMed ID: 16763012
[TBL] [Abstract][Full Text] [Related]
3. Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine.
Joshi M; Tyndale RF
Neuropharmacology; 2006 Apr; 50(5):568-75. PubMed ID: 16368115
[TBL] [Abstract][Full Text] [Related]
4. Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein.
Lee AM; Miksys S; Tyndale RF
Br J Pharmacol; 2006 Jul; 148(6):786-94. PubMed ID: 16751792
[TBL] [Abstract][Full Text] [Related]
5. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
Shaik IH; Mehvar R
J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
[TBL] [Abstract][Full Text] [Related]
6. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver.
Howard LA; Micu AL; Sellers EM; Tyndale RF
J Pharmacol Exp Ther; 2001 Nov; 299(2):542-50. PubMed ID: 11602665
[TBL] [Abstract][Full Text] [Related]
7. Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys.
Ferguson CS; Miksys S; Palmour R; Tyndale RF
Drug Metab Dispos; 2011 Dec; 39(12):2233-41. PubMed ID: 21868470
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
[TBL] [Abstract][Full Text] [Related]
9. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
Chen L; Yang CS
Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
[TBL] [Abstract][Full Text] [Related]
10. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.
Raucy JL; Schultz ED; Wester MR; Arora S; Johnston DE; Omdahl JL; Carpenter SP
Drug Metab Dispos; 1997 Dec; 25(12):1429-35. PubMed ID: 9394034
[TBL] [Abstract][Full Text] [Related]
11. Determination of brain cytochrome P450 2E1 activity in rat with the probe of chlorzoxazone by liquid chromatography-mass spectrometry.
Wu JY; Yue J; Feng YQ
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):260-6. PubMed ID: 21196134
[TBL] [Abstract][Full Text] [Related]
12. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
Wan J; Ernstgård L; Song BJ; Shoaf SE
J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
[TBL] [Abstract][Full Text] [Related]
13. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
[TBL] [Abstract][Full Text] [Related]
14. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
Park JY; Kim KA; Park PW; Ha JM
J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
Eap CB; Schnyder C; Besson J; Savary L; Buclin T
Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
[TBL] [Abstract][Full Text] [Related]
17. Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.
Stresser DM; Perloff ES; Mason AK; Blanchard AP; Dehal SS; Creegan TP; Singh R; Gangl ET
Drug Metab Dispos; 2016 Aug; 44(8):1424-30. PubMed ID: 27149898
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
Kwon MH; Lee CJ; Cho YY; Kang HE
J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
[TBL] [Abstract][Full Text] [Related]
19. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E
Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
[TBL] [Abstract][Full Text] [Related]
20. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
